Cite
HARVARD Citation
Akaev, I. et al. (n.d.). EP772 Testing for concordance of somatic and germline BRCA1/2 pathogenic mutations in ovarian cancer patients eligible for PARP inhibitors therapy: large single-site institution experience. International journal of gynecological cancer. p. A429. [Online].